Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Patient's Anastrozole Compliance to Therapy Programme (PACT)

This study has been terminated.
(High drop-out rate leads to the conclusion: not enough data will be available to perform proper analyses of data collected after follow-up month 24 visit)
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: November 7, 2007
Last updated: December 22, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):